Mable
AcquiredYC S21London, GB · Founded 2019 · 7 employees · 4 known investors
Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans. The company serves migraine sufferers seeking precision medicine alternatives to traditional trial-and-error medication approaches.
Also known as DiveHealth · Neurolytic Healthcare · Neurolytic Healthcare Ltd.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesHealth TechTelehealthGenomicsUnited KingdomUnited States of AmericaEuropeAmerica / CanadaFully Remote
Founders & leadership· Y Combinator alumni (S21)
Mable was founded in 2019 by Roman Rothaermel, Inna Thalmann, Chris Eijsbouts, and Kumeren Govnder.
RR
Roman RothaermelinFounderRoman Rothaermel holds an MSc in Biology from Tübingen University and an MSc in Neuroscience from Oxford University, where he also completed his PhD studying memory encoding and brain synchronization mechanisms. He has conducted research in neuropharmacology and drug target characterization.
IT
Inna ThalmanninFounderInna Thalmann is co-founder and chief operating officer of Mable, a precision medicine company applying genomic sequencing to clinical decision-making. She holds a PhD in Econometrics with a health economics focus from the University of Oxford and completed postdoctoral research on phenotype algorithms for clinical trial design.
CE
Chris Eijsbouts
KG
Kumeren Govnder
Investors · 4
In the news
Crypto News. July 17, 2026 - by Crypto Integratedcryptointegrat.com · Jul 2026
Multicoin Capital makes first Hyperliquid ecosystem investment in Trasia, an Asia-focused trading platform | The Blocktheblock.co · Jul 2026Frequently asked questions
- What does Mable do?
- Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans. The company serves migraine sufferers seeking precision medicine alternatives to traditional trial-and-error medication approaches.
- Who founded Mable?
- Mable was founded by Roman Rothaermel, Inna Thalmann, Chris Eijsbouts, Kumeren Govnder in 2019.
- Who are Mable's investors?
- Mable's investors include Initialized Capital, Underscore VC, Venrock, Y Combinator.
- Where is Mable headquartered?
- Mable is headquartered in London, GB.